Your browser doesn't support javascript.
loading
Laboratory biomarkers associated with COVID-19 severity and management.
Keddie, S; Ziff, O; Chou, M K L; Taylor, R L; Heslegrave, A; Garr, E; Lakdawala, N; Church, A; Ludwig, D; Manson, J; Scully, M; Nastouli, E; Chapman, M D; Hart, M; Lunn, M P.
Affiliation
  • Keddie S; Neuroimmunology and CSF laboratory, University College London Hospitals NHS Trust National Hospital of Neurology and Neurosurgery, Queen Square, London, UK. Electronic address: stephen.keddie@nhs.net.
  • Ziff O; Neuroimmunology and CSF laboratory, University College London Hospitals NHS Trust National Hospital of Neurology and Neurosurgery, Queen Square, London, UK.
  • Chou MKL; Neuroimmunology and CSF laboratory, University College London Hospitals NHS Trust National Hospital of Neurology and Neurosurgery, Queen Square, London, UK.
  • Taylor RL; Neuroimmunology and CSF laboratory, University College London Hospitals NHS Trust National Hospital of Neurology and Neurosurgery, Queen Square, London, UK.
  • Heslegrave A; UK Dementia Research Institute, University College London, London, UK.
  • Garr E; Neuroimmunology and CSF laboratory, University College London Hospitals NHS Trust National Hospital of Neurology and Neurosurgery, Queen Square, London, UK.
  • Lakdawala N; Neuroimmunology and CSF laboratory, University College London Hospitals NHS Trust National Hospital of Neurology and Neurosurgery, Queen Square, London, UK.
  • Church A; Neuroimmunology and CSF laboratory, University College London Hospitals NHS Trust National Hospital of Neurology and Neurosurgery, Queen Square, London, UK.
  • Ludwig D; Department of Rheumatology, University College London Hospitals NHS Trust, London, UK.
  • Manson J; Department of Rheumatology, University College London Hospitals NHS Trust, London, UK.
  • Scully M; Department of Haematology, University College London Hospitals NHS Foundation Trust and Cardiometabolic Programme-NIHR UCLH/UC BRC, London, UK.
  • Nastouli E; Infection control department, University College London Hospitals NHS Trust, London, UK.
  • Chapman MD; Neuroimmunology and CSF laboratory, University College London Hospitals NHS Trust National Hospital of Neurology and Neurosurgery, Queen Square, London, UK.
  • Hart M; Neuroimmunology and CSF laboratory, University College London Hospitals NHS Trust National Hospital of Neurology and Neurosurgery, Queen Square, London, UK.
  • Lunn MP; Neuroimmunology and CSF laboratory, University College London Hospitals NHS Trust National Hospital of Neurology and Neurosurgery, Queen Square, London, UK.
Clin Immunol ; 221: 108614, 2020 12.
Article in En | MEDLINE | ID: mdl-33153974
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Distress Syndrome / C-Reactive Protein / Interleukin-6 / Cytokine Release Syndrome / SARS-CoV-2 / COVID-19 Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2020 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Distress Syndrome / C-Reactive Protein / Interleukin-6 / Cytokine Release Syndrome / SARS-CoV-2 / COVID-19 Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2020 Document type: Article